Study of medroxyprogesterone: a long-acting injectable female contraceptive agent.
Ahmad
G
G
Rasul
A
A
D000367:Age Factors; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006470:Hemorrhage; D006653:Histology; D007267:Injections; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D010298:Parity; D010827:Physiology; D012106:Research; D012816:Signs and Symptoms; D014566:Urogenital System; D014599:Uterus
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Age Factors; Biology; Bleeding; Clinical Research; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Depo-provera; Diseases; Evaluation; Family Planning; Genitalia; Genitalia, Female; Histology; Injectables; Medroxyprogesterone Acetate--side effects; Menstruation Disorders; Parity; Physiology; Research Methodology; Signs And Symptoms; Urogenital System; Uterine Effects; Uterus